Company profile: Qnovia
1.1 - Company Overview
Company description
- Provider of medtech and pharmaceutical drug-delivery solutions, including RespiRx, an inhalable prescription nicotine replacement therapy for smoking cessation; an inhaled drug delivery platform that optimizes and tracks dosing to improve efficacy and compliance; and a portable, orientation-agnostic vibrating mesh nebulizer with a digital metered dose interface, Bluetooth-enabled app, and a zero-maintenance disposable cartridge.
Products and services
- Inhaled Drug Delivery Platform: An inhaled platform that optimizes and tracks dosing, increases efficacy, and improves patient compliance for a broad range of pharmaceuticals
- RespiRx: A combination-drug product engineered to be the first inhalable prescription Nicotine Replacement Therapy (NRT) for smokers trying to quit smoking
- Vibrating Mesh Nebulizer (VMN): A portable, orientation-agnostic nebulizer with a digital metered dose interface and Bluetooth-enabled mobile app functionality, complemented by a disposable cartridge requiring zero cleaning or maintenance
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Qnovia
Softhale
HQ: Belgium
Website
- Description: Provider of soft mist inhalation (SMI) devices, including an innovative handheld non-thermal mechanical nebulizer, enabling effective respiratory delivery of pharmaceutical drugs to the lungs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Softhale company profile →
OnDosis
HQ: Sweden
Website
- Description: Provider of flexible, individualized dosing of oral medicines via a Dosage Manager delivering micro-unit forms (granules, pellets, mini-tablets) with accurate dosing, plus connected services: patient app, cloud platform, and physician interface for remote monitoring, adherence support, physician-patient communication, secure data exchange, regulatory compliance, and third-party integrations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OnDosis company profile →
Lexaria Bioscience
HQ: Canada
Website
- Description: Provider of patented DehydraTECH technology that improves bio-absorption, reduces onset time, and enhances delivery of lipophilic drugs across the blood-brain barrier; out-licenses this platform and operates units focused on pharmaceuticals (hypertension, antiviral, epilepsy), oral non-combusted nicotine, hemp-derived ingredients, a Health Canada licensed lab for cannabinoid and other formulations, and nutraceutical CPG applications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lexaria Bioscience company profile →
PharmaJet
HQ: United States
Website
- Description: Provider of needle-free jet injection systems for fixed-dose intradermal, intramuscular, and subcutaneous vaccine delivery. Offerings include Tropis ID (0.1 ml intradermal), Stratis IM/SC (0.5 ml IM/SC with charging station), and platforms for nucleic acid, COVID-19 (e.g., ZyCoV-D), polio, and influenza (e.g., Afluria) vaccine delivery, enhancing cellular dispersion and immunogenicity and providing an alternative to needles.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PharmaJet company profile →
Nanoleaf
HQ: Canada
Website
- Description: Provider of licensed, globally patented biotech technologies enabling proven pharmaceutical, nutraceutical, cosmetic, and functional beverage drug delivery formulations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nanoleaf company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Qnovia
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Qnovia
2.2 - Growth funds investing in similar companies to Qnovia
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Qnovia
4.2 - Public trading comparable groups for Qnovia
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →